Literature DB >> 8095954

Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.

J Plum1, M De Smedt, G Leclercq.   

Abstract

Addition of human rIL-7 to fetal thymic organ culture started at day 13, 14, or 15 did not influence the number of cells generated during a 12-day culture period. However, the IL-7 treatment resulted in a preferential expansion of cells with a phenotype characteristic for cells at an early step of differentiation. The cells were CD4-CD8-CD3-CD2- and SCA-1+. Analysis of the coordinate expression of CD44 and CD25 on these cells showed that the majority of the cells were either CD44+CD25- or CD44+CD25intermediate. TCR-alpha beta cells were present but in a significantly lower number as compared to the control cultures. The cell number of TCR-gamma delta cells was increased. All these effects were moderate after 6 days, but unequivocal after 12 days of culture. Treatment of the fetal organ culture with mAb-neutralizing murine IL-7 resulted in an inhibition of the proliferation of the fetal thymocytes. No particular subset studied was preferentially inhibited. By using a model of reconstitution of 14-day embryonic thymuses depleted of thymocytes by deoxyguanosine and reconstituted with fetal day 13 liver cells and set up in organ culture with or without IL-7, it was shown in a clear cut way that IL-7 indeed promotes expansion of the early precursor cells and TCR-gamma delta cells, but prevents the generation of TCR-alpha beta cells. In addition, reconstitution experiments were set up in the presence of mAb-neutralizing murine IL-7. This treatment resulted in the inhibition of the growth of the fetal thymocytes without inhibiting preferentially a particular subset. These data indicate that IL-7 acts at an early step of T cell differentiation and plays a role to expand precursor cells, but prevents this population from additional differentiation towards the TCR-alpha beta pathways, whereas the differentiation towards TCR-gamma delta cells is not influenced or even enhanced.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095954

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Interleukin 7 receptor-deficient mice lack gammadelta T cells.

Authors:  K Maki; S Sunaga; Y Komagata; Y Kodaira; A Mabuchi; H Karasuyama; K Yokomuro; J I Miyazaki; K Ikuta
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation.

Authors:  Jiaxue Huang; Karla P Garrett; Rosana Pelayo; Juan Carlos Zúñiga-Pflücker; Howard T Petrie; Paul W Kincade
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

Review 3.  Immunosenescence: emerging challenges for an ageing population.

Authors:  Danielle Aw; Alberto B Silva; Donald B Palmer
Journal:  Immunology       Date:  2007-02-15       Impact factor: 7.397

4.  Interferons alpha/beta inhibit IL-7-induced proliferation of CD4- CD8- CD3- CD44+ CD25+ thymocytes, but do not inhibit that of CD4- CD8- CD3- CD44- CD25- thymocytes.

Authors:  D M Su; J Wang; Q Lin; M D Cooper; T Watanabe
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

5.  Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia.

Authors:  Camille E Puronen; William L Thompson; Hiromi Imamichi; Stephanie Beq; Jessica N Hodge; Catherine Rehm; Raphaelle Parker; Rebecca DerSimonian; Jason M Brenchley; Irini Sereti
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

6.  Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-alpha beta cells selectively to the CD8+ cell lineage.

Authors:  A Varas; A Vicente; E Jiménez; L Alonso; J Moreno; J J Muñoz; A G Zapata
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

7.  Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures.

Authors:  L F Thompson; C J Van de Wiele; A B Laurent; S W Hooker; J G Vaughn; H Jiang; K Khare; R E Kellems; M R Blackburn; M S Hershfield; R Resta
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

8.  Interleukin-7 inhibits pre-T-cell differentiation induced by the pre-T-cell receptor signal and the effect is mimicked by hGM-CSF in hGM-CSF receptor transgenic mice.

Authors:  Yuko Yasuda; Azusa Kaneko; Ichiko Nishijima; Shoichiro Miyatake; Ken-Ichi Arai
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

9.  An interleukin-2 receptor gamma chain mutation with normal thymus morphology.

Authors:  N Sharfe; M Shahar; C M Roifman
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

10.  Interleukin-7 activates intestinal lymphocytes.

Authors:  M Bilenker; A I Roberts; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.